Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 9—September 2022
Research

Fulminant Transfusion-Associated Hepatitis E Virus Infection Despite Screening, England, 2016–2020

Heli HarvalaComments to Author , Claire Reynolds, Su Brailsford, and Katy Davison
Author affiliations: University College of London, London, UK (H. Harvala); NHS Blood and Transplant, London (H. Harvala, C. Reynolds, S. Brailsford, K. Davison); UK Health Security Agency, London (K. Davison)

Main Article

Table 1

Number of donations and donors tested for hepatitis E virus RNA, number of positive results, detection rate, and incidence rate for apheresis and whole-blood donors, England, March 2016–December 2020

Donation type, year Donations Donors Positive Detection rate, no. HEV RNA detections/1 million donations Incidence rate, HEV RNA–positive samples/1 million donors
Apheresis
2016 69,605 14,952 24 344.8 1,966.5
2017 74,422 15,987 20 268.7 1,532.6
2018 70,709 15,189 24 339.4 1,935.8
2019 68,907 15,450 15 217.7 1,241.5
2020 66,680 13,593 24 359.9 2,052.7
Total
 350,323
 75,170
 107
 305.4
 1,741.9
Whole blood
2016 413,153 234,141 174 421.2 2,401.9
2017 1,256,503 712,083 261 207.7 1,184.6
2018 1,488,808 843,734 351 235.8 1,344.6
2019 1,450,628 825,363 455 313.7 1,788.8
2020 1,338,489 769,420 379 283.2 1,614.9
Total 5,947,581 3,384,741 1,620 272.4 1,553.4

Main Article

Page created: July 14, 2022
Page updated: August 19, 2022
Page reviewed: August 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external